Home
Pipeline
Breakthrough Platforms
Partnering
About us
Investor Relations
Careers
Contact

News on home

Spexis > News on home

Latest news

Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances
Spexis provides business update and announces financial results for the full year 2022

This site uses cookies: Find out more.